Flora K P, van't Riet B, Wampler G L
Cancer Res. 1978 May;38(5):1291-5.
A series of amidoximes was prepared and evaluated for possible antitumor activity against L1210 leukemia. Three of the most active compounds in the L1210 system, formamidoxime, acetamidoxime, and 2-aminoacetamidoxime hydrochloride, were also active against P388 leukemia. Acetamidoxime was marginally active against Lewis lung carcinoma. The active amidoximes showed best activity against L1210 leukemia when given two times daily, 5 hours apart, for 8 days. Most of the amidoximes produced excessive central nervous system stimulation.
制备了一系列偕胺肟,并评估了它们对L1210白血病的潜在抗肿瘤活性。在L1210系统中活性最高的三种化合物,即甲脒肟、乙脒肟和盐酸2-氨基乙脒肟,对P388白血病也有活性。乙脒肟对Lewis肺癌有微弱活性。活性偕胺肟在每天给药两次、间隔5小时、持续8天的情况下,对L1210白血病显示出最佳活性。大多数偕胺肟会产生过度的中枢神经系统刺激。